Capitale Ordinario Cambiamento Data
Acadia Pharmaceuticals USD 172.31M 174K 2026-09
ALKERMES USD 168.03M 489K 2026-09
Alnylam Pharmaceuticals USD 133.88M 141K 2026-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 193.68M 141K 2026-09
Bristol-Myers Squibb USD 2.04B 7M 2026-06
Cara Therapeutics USD 9.38M 2.01K 2026-03
Corcept Therapeutics USD 109.36M 1.44M 2026-09
Cytokinetics USD 138.76M 14.33M 2026-06
Eisai JPY 282.46M 0 2026-09
Eli Lilly USD 943.5M 3.33M 2026-03
Incyte USD 200.98M 1.03M 2026-06
J&J USD 2.41B 1.64M 2026-06
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 101.3M 750K 2026-09
Pfizer USD 5.7B 1000K 2026-09
Prothena USD 51.74M 1.33M 2026-06
PTC Therapeutics USD 83.33M 445K 2026-06
Sarepta Therapeutics USD 107.23M 1.61M 2026-09
Ultragenyx Pharmaceutical USD 98.6M 300K 2026-06
Vanda Pharmaceuticals USD 58K 0 2024-12
Vertex Pharmaceuticals USD 253.5M 200K 2026-09